Enimmune corporation Market Cap

Enimmune corporation has a market cap or net worth of 1.15 billion as of June 13, 2025. Its market cap has decreased by -51.17% in one year.

Market Cap

1.15B

Enterprise Value

870.07M

Revenue

39.92M

Ranking

n/a

PE Ratio

n/a

Stock Price

16.40

Market Cap Chart

Since September 18, 2018, Enimmune corporation's market cap has decreased from 1.33B to 1.15B, a decrease of -13.66%. That is a compound annual growth rate of -2.16%.

Market Cap History

Date	Market Cap	% Change
Jun 10, 2025	1.20B	-33.33%
Dec 31, 2024	1.80B	-27.21%
Dec 29, 2023	2.47B	-38.63%
Dec 30, 2022	4.02B	69.85%
Dec 30, 2021	2.37B	-11.74%
Dec 31, 2020	2.68B	155.47%
Dec 31, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	181.96B
Caliway Biopharmaceuticals	154.45B
Bora Pharmaceuticals Co., LTD.	83.79B
Lotus Pharmaceutical	58.50B
Oneness Biotech	33.29B
Polaris Group	31.13B
Lumosa Therapeutics	28.28B
Center Laboratories	27.49B

Market Cap Rankings